Skip to content
healthcare.dev

Metronidazole

NDC 16571-664, Metronidazole, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-664
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203974
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METRONIDAZOLE500 mg/1

Pharmacologic classes

Nitroimidazole Antimicrobial [EPC]; Nitroimidazoles [CS]

Package NDCNDC-11Package
16571-664-0116571066401100 TABLET in 1 BOTTLE (16571-664-01)
16571-664-5016571066450500 TABLET in 1 BOTTLE (16571-664-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/93e4f174-4fe0-4cfd-a0cf-d0963e082107
  • NADAC price for package 16571066401

    GET /v1/drugs/nadac/16571066401
  • NADAC price for package 16571066450

    GET /v1/drugs/nadac/16571066450

Use it

Look up 16571-664 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-664 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-664. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.